Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Applications of four kaurane diterpene compounds in preparation of glycosidase inhibitor medicines

A glycosidase inhibitor, kaurine-type technology is applied to the application field of four kaurine diterpenoid compounds in the preparation of glycosidase inhibitor drugs, and the preparation process is easy to operate, high in safety and rich in sources.

Active Publication Date: 2014-10-08
SOUTH CHINA BOTANICAL GARDEN CHINESE ACADEMY OF SCI
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Compounds 3α-hydroxy-ent-kauran-19-oic acid (1), 3α-tigloyloxy-9β-hydroxy-ent-kaur-16-en-19-oic acid (2), 3α-cinnamoyloxy-ent-kaur-16 -en-19-oic acid (3), 3α-cinnamoyloxy-9β-hydroxy-ent-kaur-16-en-19-oic acid (4) are all kaurane diterpene compounds, these compounds have been obtained from three Split leaf Wedelia (Wedelia trilobata (L.) Hitchc) isolated from (Qiang et al., Helvetica Chimica Acta2011,94:817-823; Bohlmann et al., Phytochemistry1981,20:751-756; Ma et al., Natural Products and Bioprospecting, 2013, 3:107-111), its chemical structural formula is shown in the following formula (I), but so far there is no research report on its glycosidase inhibitor activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of four kaurane diterpene compounds in preparation of glycosidase inhibitor medicines
  • Applications of four kaurane diterpene compounds in preparation of glycosidase inhibitor medicines
  • Applications of four kaurane diterpene compounds in preparation of glycosidase inhibitor medicines

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Embodiment 1: Preparation of four kinds of diterpene compounds in Wedelia chinensis

[0018] 1.1 Plant source and identification

[0019] The plant material for extraction, Sphagneticola trilobata (L.) Pruski, was collected from the South China Botanical Garden in Guangdong Province in September 2009 and identified by Xing Fuwu, a researcher at the South China Botanical Garden, Chinese Academy of Sciences.

[0020] 1.2 Extraction and separation

[0021] The whole plant of Wedelia chinensis (dry weight 2kg) was pulverized, soaked and extracted with ethanol with a volume fraction of 95% at room temperature for 3 times, each time for 2 days, and the extracts were combined; the ethanol in the extract was drained by concentration under reduced pressure, and then an appropriate amount of water was added to make it It became a suspension, which was extracted 4 times with petroleum ether; the petroleum ether fraction (45 g) was obtained after concentration under reduced pressu...

Embodiment 2

[0026] Embodiment 2: The α-glucosidase inhibitory activity detection of described four kinds of diterpene compounds

[0027] 2.1 Instruments and reagents

[0028] Experimental instrument: Genois microplate reader (Tecan GENios, Swizerland)

[0029] Reagent samples: α-glucosidase was purchased from Sigma Chemical Co. (Sigma-Aldrich, St.Louis, USA); Acarbose was purchased from Tokyo Chemical Industry Co., Ltd. (Japan); Phenylphenol-α-D-glucopyranoside (PNPG) was purchased from Tokyo Chemical Industry Co., Ltd. (Japan); four diterpene compounds α-hydroxy-ent-kauran-19-oic acid (compound 1), 3α-tigloyloxy-9β-hydroxy-ent-kaur-16-en-19-oic acid (compound 2), 3α-cinnamoyloxy-ent-kaur-16-en-19-oic acid (compound 3), 3α-cinnamoyloxy- 9β-hydroxy-ent-kaur-16-en-19-oic acid (compound 4) is prepared from the above experimental example 1 or can also refer to the literature Qiang et al., Helvetica Chimica Acta2011, 94:817-823; Bohlmann et al ., Phytochemistry1981, 20:751-756; Ma et al., N...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides applications of four kaurane diterpene compounds in preparation of glycosidase inhibitor medicines. The four compounds capable of highly inhibiting alpha-glycosidase activity are natural compounds which are high in safety and capable of rapid natural degradation without residue in the environment. The four compounds are obtained by separation from wedelia trilobata, and other plant materials. The plant materials are rich in source. A preparation process is easy in operation. Monomers of the four compounds are stable and liable to store. The alpha-glucosidase inhibition activity of the four compounds is obviously higher than or equivalent to that of acarbose that is a clinic medicine. The four compounds are extremely likely developed into effective and safe alpha-glucosidase inhibitor medicines used for preventing and treating type II diabetes, and have good prospects.

Description

technical field [0001] The invention belongs to the field of natural medicinal chemistry, in particular to four kaurane diterpene compounds 3α-hydroxy-ent-kaura n-19-oic acid (1), 3α-tigloyloxy-9β-hydroxy-ent-kaur-16-en -19-oic acid (2), 3α-cinnamoyloxy-ent-kaur-16-en-19-oic acid (3), 3α-cinnamoyloxy-9β-hydroxy-ent-kaur-16-en-19-oic acid ( 4) Application of the pharmaceutically acceptable salt thereof in the preparation of glycosidase inhibitors or medicines. Background of the invention [0002] Diabetes is a clinically common endocrine and metabolic disorder disease, which has an important correlation with the annual increase in cardiovascular diseases and cancers, and is an important killer of human health. At present, the incidence of diabetes is increasing worldwide. In my country, the prevalence of diabetes is more than 100 million, and it shows a trend of increasing year by year. Diabetes is causing more and more serious losses to our people's health and national eco...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/19A61K31/22A61K31/216A61P3/10
Inventor 谭建文任慧周忠玉徐巧林董丽梅
Owner SOUTH CHINA BOTANICAL GARDEN CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products